Janet M Raboud
Overview
Explore the profile of Janet M Raboud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gillis J, Grennan T, Grewal R, Ogilvie G, Gaspar M, Grace D, et al.
BMC Public Health
. 2022 Dec;
22(1):2444.
PMID: 36577960
Background: Implementation of anal cancer screening requires the procedure to be acceptable to the target population. Our objective was to assess the beliefs of men living with HIV regarding anal...
2.
Paul L, Bayoumi A, Chen C, Kocovska E, Smith B, Raboud J, et al.
Addiction
. 2022 Nov;
118(4):686-697.
PMID: 36401610
Aims: Although opioid-related harms have reached new heights across North America, the size of the gap in opioid agonist therapy (OAT) delivery for opioid-related health problems is unknown in most...
3.
Christensen B, Tavangar F, Kroch A, Burchell A, Rourke S, Rousseau R, et al.
Sex Transm Dis
. 2022 Sep;
50(1):34-41.
PMID: 36150077
No abstract available.
4.
Grewal R, Grennan T, Gillis J, Ogilvie G, Gaspar M, Grace D, et al.
Prev Med
. 2020 Nov;
143:106329.
PMID: 33221269
Men living with human immunodeficiency virus (HIV) are internationally recognized as a priority population for human papillomavirus (HPV) vaccination. Our objective was to explore HPV vaccine uptake among men living...
5.
Gillis J, Grennan T, Grewal R, Ogilvie G, Gaspar M, Grace D, et al.
Prev Med
. 2020 Oct;
141:106274.
PMID: 33022315
Human papillomavirus (HPV)-associated anal cancer is orders of magnitude higher among men living with HIV than the general male population. Our objective was to examine factors associated with HPV awareness...
6.
Gillis J, Grennan T, Grewal R, Ogilvie G, Gaspar M, Grace D, et al.
J Acquir Immune Defic Syndr
. 2020 Feb;
84(3):295-303.
PMID: 32097251
Background: Our objective was to quantify the extent of anal cancer screening among men receiving HIV specialty care in Ontario, Canada, and evaluate factors associated with screening. Setting: Cross-sectional questionnaire...
7.
Lesosky M, Raboud J, Glass T, Brummel S, Ciaranello A, Currier J, et al.
AIDS
. 2019 Oct;
34(2):311-315.
PMID: 31634186
Background: Intensified viral load monitoring for pregnant and breastfeeding women has been proposed to help address concerns around antiretroviral therapy (ART) adherence, viraemia and transmission risk, but there have been...
8.
Tan D, Rolon M, Figueroa M, Sued O, Gun A, Kaul R, et al.
PLoS One
. 2019 Sep;
14(9):e0221653.
PMID: 31490959
Background: Inflammation has been associated with increased morbidity and mortality in HIV-positive patients. We compared inflammatory biomarkers with dual therapy using lopinavir/ritonavir plus lamivudine (LPV/r+3TC) versus triple therapy using LPV/r...
9.
Tan D, Schnubb A, Lawless J, Szadkowski L, Grennan T, Wilton J, et al.
CMAJ Open
. 2018 Dec;
6(4):E611-E617.
PMID: 30530721
Background: Preexposure prophylaxis is efficacious at preventing HIV infection, but concerns persist about adherence and sexually transmitted infections (STIs). We assessed preexposure prophylaxis acceptability, adherence and clinical outcomes in a...
10.
Tan D, Raboud J, Szadkowski L, Grinsztejn B, Valdez Madruga J, Figueroa M, et al.
J Antimicrob Chemother
. 2018 Oct;
74(2):480-488.
PMID: 30376108
Objectives: To determine the impact of valaciclovir on HIV disease progression in treatment-naive HIV-positive adults. Methods: In this fully blind, multicentre, 1:1 randomized placebo-controlled trial, treatment-naive HIV-1-positive adults with CD4...